116 related articles for article (PubMed ID: 1666264)
1. Ca/CaM-stimulated and cGMP-specific phosphodiesterases in vascular and non-vascular tissues.
Ahn HS; Foster M; Cable M; Pitts BJ; Sybertz EJ
Adv Exp Med Biol; 1991; 308():191-7. PubMed ID: 1666264
[No Abstract] [Full Text] [Related]
2. Age related changes in cardiac and aortic phosphodiesterase activities in normotensive and hypertensive rats.
Lugnier C; Stoclet JC
Biochem Pharmacol; 1979 Dec; 28(24):3581-7. PubMed ID: 231449
[No Abstract] [Full Text] [Related]
3. Distribution and regulation of the phosphodiesterases of muscle tissues.
Gain KR; Appleman MM
Adv Cyclic Nucleotide Res; 1978; 9():221-31. PubMed ID: 208376
[No Abstract] [Full Text] [Related]
4. cGMP signal termination.
Pyne NJ; Arshavsky V; Lochhead A
Biochem Soc Trans; 1996 Nov; 24(4):1019-22. PubMed ID: 8968504
[No Abstract] [Full Text] [Related]
5. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
Hidaka H; Endo T
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
[No Abstract] [Full Text] [Related]
6. Multiple forms of cyclic nucleotide phosphodiesterases: anomalies or biologic regulators?
Strada SJ; Thompson WJ
Adv Cyclic Nucleotide Res; 1978; 9():265-83. PubMed ID: 208379
[No Abstract] [Full Text] [Related]
7. Effect of acupuncture on the activities of phosphodiesterases in rat brain.
Zhang TJ; Ma CH; Sun SM; Dong XT; Lu ZS
J Tradit Chin Med; 1985 Dec; 5(4):285-8. PubMed ID: 3010000
[No Abstract] [Full Text] [Related]
8. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
Bellamy TC; Garthwaite J
Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of tyrosine 698 in beta subunit of cGMP phosphodiesterase in patients with retinitis pigmentosa and population of the west of Mexico.
Núñez-Gutiérrez IC; García-Cruz D; Fragoso-Herrera R; Medina-Lozano C
Rev Invest Clin; 2006; 58(4):359-61. PubMed ID: 17146947
[No Abstract] [Full Text] [Related]
10. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
11. Differential susceptibility to biological detergents of the particulate cGMP-stimulated phosphodiesterase from rat heart: preservation of the allosteric properties of the solubilized enzyme.
Timouyasse L; Prigent AF; Némoz G; Lagarde M; Pachéco H
Biochem Int; 1989 Aug; 19(2):287-99. PubMed ID: 2554908
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
Schermuly RT; Pullamsetti SS; Kwapiszewska G; Dumitrascu R; Tian X; Weissmann N; Ghofrani HA; Kaulen C; Dunkern T; Schudt C; Voswinckel R; Zhou J; Samidurai A; Klepetko W; Paddenberg R; Kummer W; Seeger W; Grimminger F
Circulation; 2007 May; 115(17):2331-9. PubMed ID: 17438150
[TBL] [Abstract][Full Text] [Related]
13. Calcium-regulated protein kinases and low Km cGMP phosphodiesterases: targets for novel antihypertensive therapy.
Silver PJ; Pagani ED; Cumiskey WR; Dundore RL; Harris AL; Lee KC; Ezrin AM; Buchholz RA
Adv Exp Med Biol; 1991; 308():95-105. PubMed ID: 1666269
[No Abstract] [Full Text] [Related]
14. Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.
Rybalkin SD; Bornfeldt KE; Sonnenburg WK; Rybalkina IG; Kwak KS; Hanson K; Krebs EG; Beavo JA
J Clin Invest; 1997 Nov; 100(10):2611-21. PubMed ID: 9366577
[TBL] [Abstract][Full Text] [Related]
15. Identification, quantitation, and cellular localization of PDE1 calmodulin-stimulated cyclic nucleotide phosphodiesterases.
Sonnenburg WK; Rybalkin SD; Bornfeldt KE; Kwak KS; Rybalkina IG; Beavo JA
Methods; 1998 Jan; 14(1):3-19. PubMed ID: 9500854
[TBL] [Abstract][Full Text] [Related]
16. Cyclic nucleotide phosphodiesterase activity in normal mice and mice with retinal degeneration.
Robb RM
Invest Ophthalmol Vis Sci; 1979 Oct; 18(10):1097-100. PubMed ID: 225287
[No Abstract] [Full Text] [Related]
17. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle.
Park K; Moreland RB; Goldstein I; Atala A; Traish A
Biochem Biophys Res Commun; 1998 Aug; 249(3):612-7. PubMed ID: 9731184
[TBL] [Abstract][Full Text] [Related]
18. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells.
Wyatt TA; Naftilan AJ; Francis SH; Corbin JD
Am J Physiol; 1998 Feb; 274(2):H448-55. PubMed ID: 9486247
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
[TBL] [Abstract][Full Text] [Related]
20. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
Rybalkin SD; Bornfeldt KE
Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
